INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $704 | +19.7% | 27,881 | 0.0% | 0.00% | +33.3% |
| Q2 2023 | $588 | +17.4% | 27,881 | -5.1% | 0.00% | 0.0% |
| Q1 2023 | $501 | +38.0% | 29,381 | +61.6% | 0.00% | +50.0% |
| Q4 2022 | $363 | -99.9% | 18,181 | +23.0% | 0.00% | 0.0% |
| Q3 2022 | $318,000 | -14.1% | 14,781 | -21.3% | 0.00% | 0.0% |
| Q2 2022 | $370,000 | -16.1% | 18,781 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $441,000 | -32.3% | 18,781 | -21.4% | 0.00% | -33.3% |
| Q4 2021 | $651,000 | -1.1% | 23,881 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $658,000 | -3.2% | 23,881 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $680,000 | +3.0% | 23,881 | +23.2% | 0.00% | 0.0% |
| Q1 2021 | $660,000 | +2.3% | 19,381 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $645,000 | +3.5% | 19,381 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $623,000 | -7.0% | 19,381 | -20.4% | 0.01% | +66.7% |
| Q2 2020 | $670,000 | – | 24,362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |